Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
A phase 1/2 trial of BHB810 in gastric & gastro-oesophageal junction cancer, oesophageal cancer, colorectal cancer and pancreatic ductal adenocarcinoma, run by BigHat Biosciences, Inc., now recruiting.
Overview
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma is a phase 1/2 interventional study registered as NCT07529808 by BigHat Biosciences, Inc., with 164 participants planned, started 2026-07 and due to reach its primary completion in 2028-12. Interventions recorded: BHB810.
Similar pages
not linked directly; found by shared links- Trial64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
- TrialFeasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
- TrialLead-212 PSV359 Therapy for Patients With Solid Tumors
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
- TrialSL-28 for Advanced Solid Tumours
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialA Study of MT-4561 in Patients With Various Advanced Solid Tumors
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma and the tag pipeline.
- TrialDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Colorectal cancer and the tag pipeline.
- TrialA Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Shares Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
- TrialA Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
Shares Oesophageal cancer, Gastric & gastro-oesophageal junction cancer and the tag pipeline.